У нас вы можете посмотреть бесплатно MDR-TB: Past, present & future | World TB Day 2021 - Dr. Suresh Kumar, Infectious Diseases [2x] или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
On this occasion of World Tuberculosis Day 2021, learn about the evolution of multi-drug resistant tuberculosis (MDR-TB) and the therapies to combat the same. An established hurdle in the path of stopping tuberculosis, MDR-TB presents a diagnostic and therapeutic challenger to the practitioner. Join Dr Suresh Kumar, an eminent Infectious Diseases expert, in this 2x 10Min CME as he narrates an experience of treating MDR-TB and uses it to show us how to navigate the many hurdles in the diagnosis and management of MDR-TB. Chapters MDR-TB: Past, present & future 00:00 - 00:17 World TB Day Message 00:18 - 00:48 Purpose of World TB Day 00:49 - 01:15 Faculty introduction 01:16 - 01:36 Learning objectives 01:37 - 03:05 Case introduction and initial management 03:06 - 03:28 Approach at presentation 03:29 - 03:55 Treatment of recurrent lymph node TB 03:56 - 04:14 Patient returns with symptoms 04:15 - 04:29 Treatment options 04:30 - 05:00 MDR-TB: A real problem 05:01 - 05:40 Disease burden of MDR-TB in 2021 05:41 - 07:51 Approach to rifampin-resistant lymph node TB 07:52 - 08:13 Treatment course rationale 08:14 - 09:06 Treatment course and side effects 09:07 - 09:58 2011 MDR-TB Drug Classification 09:59 - 10:46 2011 MDR-TB regimen planning 10:47 - 11:42 2016 updates to MDR-TB drug classification 11:43 - 12:21 2016 MDR-TB regimen planning 12:22- 13:18 Modification of patient regimen 13:19 - 15:53 Toxicity of MDR-TB drugs: Presentation and associations 15:54 - 16:47 Follow-up after stopping therapy 16:48 - 18:05 2018 updates to MDR-TB drugs 18:06 - 18:31 IDSA & ATS guideline updates 18:32 - 19:37 IDSA 2019 updates 19:38 - 20:10 2019 IDSA regimen planning 20:11 - 20:51 Dosing of MDR-TB drugs 20:52 - 21:37 Reduced duration of therapy? Possible 21:38 - 22:05 Bangladesh regimen and its caveats 22:06 - 22:45 Injectable agents: Yes or No? 22:46 - 23:33 Evolution of therapy of TB 23:34 - 24:00 Lessons from the pandemic 24:01 - 24:10 Role of AI/ Machine Learning 24:11 - 25:16 Evolution of TB campaigns and therapies --------------------------------------------------------------------------------------------------------------------------- For our free learning material, please subscribe at this link: https://forms.gle/vnn6uPNuN5wVyBUy6 Subscribe for more videos like this and learn on-the-go. / 10mincme Please follow us on Instagram: / We thank you for watching and would appreciate your comments & feedback in the section below.